A detailed history of Tiaa, Fsb transactions in Novo Nordisk A S stock. As of the latest transaction made, Tiaa, Fsb holds 4,540 shares of NVO stock, worth $390,530. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,540
Previous 5,024 9.63%
Holding current value
$390,530
Previous $799,000 8.14%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$155.98 - $172.65 $75,494 - $83,562
-484 Reduced 9.63%
4,540 $734,000
Q1 2023

Apr 19, 2023

BUY
$132.34 - $159.14 $19,321 - $23,234
146 Added 2.99%
5,024 $799,000
Q4 2022

Jan 12, 2023

SELL
$102.55 - $135.33 $47,480 - $62,657
-463 Reduced 8.67%
4,878 $660,000
Q3 2022

Oct 11, 2022

BUY
$95.28 - $116.93 $2,572 - $3,157
27 Added 0.51%
5,341 $532,000
Q2 2022

Aug 09, 2022

SELL
$103.24 - $121.81 $1.94 Million - $2.28 Million
-18,757 Reduced 77.92%
5,314 $592,000
Q1 2022

Apr 13, 2022

SELL
$93.1 - $112.54 $4,934 - $5,964
-53 Reduced 0.22%
24,071 $2.67 Million
Q4 2021

Feb 01, 2022

SELL
$95.88 - $117.08 $140,272 - $171,288
-1,463 Reduced 5.72%
24,124 $2.7 Million
Q3 2021

Oct 14, 2021

BUY
$84.42 - $106.62 $72,432 - $91,479
858 Added 3.47%
25,587 $2.46 Million
Q2 2021

Jul 21, 2021

BUY
$67.66 - $84.76 $9,810 - $12,290
145 Added 0.59%
24,729 $2.07 Million
Q1 2021

Apr 21, 2021

BUY
$67.06 - $75.82 $74,168 - $83,856
1,106 Added 4.71%
24,584 $1.66 Million
Q4 2020

Jan 21, 2021

BUY
$63.89 - $73.8 $1,980 - $2,287
31 Added 0.13%
23,478 $1.64 Million
Q3 2020

Oct 13, 2020

SELL
$63.69 - $70.22 $194,509 - $214,451
-3,054 Reduced 11.52%
23,447 $1.63 Million
Q2 2020

Jul 15, 2020

SELL
$58.54 - $67.94 $82,775 - $96,067
-1,414 Reduced 5.07%
26,501 $1.74 Million
Q1 2020

Apr 21, 2020

SELL
$49.46 - $64.78 $70,381 - $92,181
-1,423 Reduced 4.85%
27,915 $1.68 Million
Q4 2019

Jan 13, 2020

BUY
$49.86 - $58.26 $11,268 - $13,166
226 Added 0.78%
29,338 $1.7 Million
Q3 2019

Oct 08, 2019

BUY
$47.54 - $53.43 $16,781 - $18,860
353 Added 1.23%
29,112 $1.51 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $829,259 - $929,925
17,723 Added 160.59%
28,759 $1.47 Million
Q1 2019

Apr 15, 2019

SELL
$46.36 - $52.63 $64,950 - $73,734
-1,401 Reduced 11.26%
11,036 $577,000
Q4 2018

Apr 15, 2019

BUY
$41.54 - $47.25 $516,632 - $587,648
12,437 New
12,437 $573,000
Q4 2018

Feb 22, 2019

SELL
$41.54 - $47.25 $517,256 - $588,357
-12,452 Closed
0 $0
Q3 2018

Oct 18, 2018

SELL
$46.76 - $51.24 $327 - $358
-7 Reduced 0.06%
12,452 $587,000
Q2 2018

Jul 20, 2018

SELL
$44.29 - $50.42 $4,827 - $5,495
-109 Reduced 0.87%
12,459 $575,000
Q1 2018

Apr 18, 2018

SELL
$48.49 - $58.14 $81,075 - $97,210
-1,672 Reduced 11.74%
12,568 $619,000
Q4 2017

Jan 29, 2018

BUY
$47.53 - $53.73 $31,417 - $35,515
661 Added 4.87%
14,240 $764,000
Q3 2017

Oct 24, 2017

BUY
$41.15 - $49.22 $558,775 - $668,358
13,579
13,579 $654,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $194B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tiaa, Fsb Portfolio

Follow Tiaa, Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.